MetaCap

CAMP4 Therapeutics Corporation Company Profile

NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.79-0.21 (-5.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CAMP4 Therapeutics at a glance

CAMP4 Therapeutics Corporation (NASDAQ: CAMP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Watertown, MA. CAMP4 Therapeutics is led by Mr. Joshua Mandel-Brehm and employs about 48 people. The company's shares have traded publicly since 2024.

At a market capitalization of $237.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001736730, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does CAMP4 Therapeutics do?

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
CAMP4 Therapeutics Corporation
Ticker
NASDAQ: CAMP
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Joshua Mandel-Brehm
Employees
48
Headquarters
100 Talcott Avenue, Watertown, MA, United States
Phone
617 651 8867
IPO year
2024
Market cap
$237.84M
SEC CIK
0001736730
Latest annual report
10-K · Mar 5, 2026

Companies similar to CAMP4 Therapeutics

CAMP peer companies
CompanyPrice% ChgMarket capCompare
LFCRLifecore Biomedical Inc.6.39+0.31%$242.22Mvs CAMP
TTRXTurn Therapeutics Inc.8.10-6.31%$247.49Mvs CAMP
QTTBQ32 Bio Inc.8.34-1.65%$249.57Mvs CAMP
ENTAEnanta Pharmaceuticals Inc.7.62-4.51%$222.19Mvs CAMP
IMRXImmuneering Corporation Class A3.38-2.03%$218.90Mvs CAMP
RCKTRocket Pharmaceuticals Inc.1.95-7.58%$217.74Mvs CAMP
KROSKeros Therapeutics Inc.11.08-2.72%$217.44Mvs CAMP
PRLDPrelude Therapeutics Incorporated3.23-0.77%$258.63Mvs CAMP

Related